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Abstract
Rapid diagnosis is one of the best ways to improve patient management and prognosis as
well as to combat the development of bacterial resistance. The aim of this study was to
study parameters that impact the achievement of reliable identification using a combination
of flow cytometry and matrix-assisted laser desorption ionization time-of-flight mass spec-
trometry (MALDI-ToF-MS).The study was carried out in nine hospitals in Spain and included
1,050 urine samples with bacterial counts of 5x106 bacteria/ml. MALDI-ToF-MS-based iden-
tification was performed according to a previously described protocol. Valid identification by
direct MALDI-ToF-MS was obtained in 72.8% of samples, in 80.3% of samples found to be
positive by culture, 32.2% of contaminated samples, and 19.7% of negative samples.
Among the positives samples with a valid identification the concordance at the species level
was 97.2%. The parameters related to success of direct identification were: high bacterial
count, the presence of Escherichia coli as a pathogen and rod-bacteria morphology pro-
vided by flow cytometry. The parameters related to failure were a high epithelial cell (EC)
count, a high white blood cell (WBC) count and urine samples obtained from in-patients. In
summary, this multicentre study confirms previously published data on the usefulness and
accuracy of direct MALDI-ToF-MS-based identification of bacteria from urine samples. It
seems important to evaluate not only the bacterial count, but also other parameters, such as
EC and WBC counts, bacterial species and morphology, and the health care setting, to
decide whether the sample is suitable for direct identification.
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Introduction
Urinary tract infection (UTI) is one of the most frequent infections attended in primary care
and hospital settings [1, 2]. UTI is an important cause of morbidity and mortality as well as
one of the major causes of prescribing antimicrobial therapy[3, 4]. In recent years we have
observed a rise in bacterial resistance, not only in hospitals but also in the community[5]. This
makes the choice of appropriate empirical therapy difficult and could have a negative impact
on patient outcomes. Therefore, there is a need for rapid diagnostic tools which could improve
patient management and treatment, especially in patients with pyelonephritis and urinary sep-
sis, providing rapid and accurate information within a few hours.
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI--
ToF-MS) has become a standard method for bacterial identification (ID) in most of Clinical
Microbiology laboratories, mainly in colonies of microorganisms grown on culture media.
Although MALDI-ToF-MS can be used for ID from direct biological samples, it has several
limitations. There is a need for sufficient numbers of bacterial cells and sample volume. The
presence of human cells as well as proteins and other organic components requires sample
preparation before analysis with MALDI-ToF-MS. Successful direct ID from urine samples
has been previously reported[6, 7]. Nevertheless, urine is the most common sample processed
in microbiological laboratories. The rate of negative samples can be of up to 60–70% of total
urine samples received [8, 9]. Flow cytometry can classify and count different cells present in
the sample, including human cells and bacteria. Currently this method is widely used for the
detection of negative urine samples to avoid their cultivation [10, 11]. Several studies have
shown the utility of flow cytometry to identify positive urine samples prior to MALDI--
ToF-MS-based ID [12–14]. However, these were single-centre studies. In addition, parameters
other than bacterial count provided by flow cytometry may be important and their impact on
direct identification should be investigated. The aim of this multicentre study was to evaluate
the efficacy and accuracy of a combination of flow cytometry and MALDI-ToF-MS for direct
ID from urine samples, using a previously described protocol for direct ID [13] without chang-
ing the routine culture and identification procedure for each participant, and while also evalu-
ating parameters that affect the achievement of direct identification for future improvements
in the sample preparation protocol.
Materials and methods
The study was conducted in two periods, from May to July and from September to November
2016 in nine hospitals in Spain (Hospital Universitari Arnau de Vilanova de Lleida (a median
of 150 urine samples processed per day), Hospital General Universitario de Elche (80 samples
per day), Hospital Universitario Marque´s de Valdecilla (80 samples per day), Hospital Univer-
sitario Reina Sofı´a de Co´rdoba (120 samples per day), Complejo Hospitalario Universitario
Santiago (250 samples per day), Hospital Universitario Principe de Asturias (190 samples per
day), Hospital Universitario Puerta de Hierro de Majadahonda (200 samples per day), Hospital
Universitario Ramo´n y Cajal (350 samples per day), Complejo Hospitalario de Jae´n (100 sam-
ples per day). Six out of the nine participating centres used tubes with a preservative agent.
Samples from all centres but one were transported with refrigeration. Patient data were col-
lected and anonymized before the analysis was performed. Based on the 86.4% of reliable
direct ID obtained in a previous study with samples with a bacterial count of 5,000 bacteria/μl
by flow cytometry and considering a non-inferiority limit of 75% and admitting 10% of losses,
it was estimated that 118 samples were needed from each participating centre [13]. Samples
were collected, transported and processed for urine culture according to the routine protocol
of each centre. During working hours, all samples received were processed by flow cytometry
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and samples that achieved the cut-off value of 5,000 bacteria/μl were randomly included in the
study. Bacterial identification of colonies grown on culture media was performed using con-
ventional techniques according to the routine procedure of each participating centre and
included chromogenic media, the MicroScan system (Beckman Coulter, Spain), the Wider sys-
tem (Francisco Soria Melguizo, Spain) and MALDI-ToF-MS, depending on the centre. Flow
cytometry was performed using UF-1000i (Sysmex, Kobe, Japan) in accordance with the man-
ufacturer’s instructions. All centres followed the guidelines of the Spanish Society of Infectious
Diseases and Clinical Microbiology (SEIMC) for performing quantitative urine culture and
criteria of positivity. Generally, a culture was considered to be positive when� 100,000 col-
ony-forming units per millilitre (CFU/ml) of one or two microorganisms were isolated, and
negative, when no growth was detected. Among samples with< 100,000 CFU/ml, the number
and species (commensal flora) of microorganisms isolated, as well as clinical data were taken
into account to consider a culture as positive or contaminated. Samples with three or more
microorganisms were considered as contaminated.
MALDI-ToF-MS-based identification was performed according to a previously described
protocol [13]. Briefly, 10 ml of urine were centrifuged at 850 g for 5 min; then, the supernatant
was centrifuged at 15,500 g for 2 min; the pellet obtained was washed twice with sterile water
and used for ID by MALDI-ToF-MS (Fig 1). Each sample was processed in duplicate using
two spots on a spectrometer plate. All but one of the centres used MALDI-TOF Microflex LT
(Bruker DaltoniK GmbH). The remaining centre used VITEK-MS (bioMe´rieux, France).
Identifications were carried out according to the manufacturer’s instructions. Valid ID for
Microflex LT was considered if the same ID was obtained with a score of� 1.7 for the first
option from both spots or for the first two options from the list of one spot if the second spot
did not provide a reliable identification or no peaks were detected. A valid ID for VITEK MS
was considered when the two spots provided the same species identification with a confidence
value of 99.9%.
Statistical analysis
Descriptive statistics, including mean, standard deviation (SD), median and range for continu-
ous variables and frequency and percent for categorical variables are provided by group.
Fig 1. Scheme of the study protocol.
https://doi.org/10.1371/journal.pone.0207822.g001
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Statistical significance (P-value) between two independent subgroups was obtained using the
Fisher’s exact test for categorical variables and the Student’s t-test for continuous variables. If
the analysis of variance assumptions were violated (e.g. non-normality or heterogeneity) the
comparison of continuous variables was performed using non-parametric tests: the Mann–
Whitney U test in the case of two subgroups or the Kruskal-Wallis test in the case of more
than two subgroups. A P value less than 0.05 was considered statistically significant. Multivari-
ate logistic regression was applied by stepwise selection and adjusting for the effect of the cen-
tre to obtain the parameters associated with valid direct ID in positive urine samples. The
effect of each parameter is presented with an odds ratio and 95% confidence interval.
Ethical approval
The study was reviewed and approved by the Hospital Universitari Arnau de Vilanova de
Lleida Institutional Review Board (IRB), acting as the single reference IRB (29/06/2016). The
study was carried out without additional intervention of patients. All the samples were pro-
cessed for the diagnosis of UTI as ordered by clinicians, and patient data were anonymized
before the analysis. Informed Consent was not required.
Results
After excluding samples with lost data, a total of 1050 urine samples were analysed. Table 1
shows the main characteristics of the samples included. A total of 224 (23.2%) samples were
from male and 806 (76.8%) from female patients. Of 902 samples positive by urine culture, 870
(96.5%) had�105 CFU/ml, 30 (3.3%) samples had�104 CFU/ml and two samples (0.2%) had
�103 CFU/ml.
Pathogens isolated from positive urine samples were: Escherichia coli (70.6%), Klebsiella
spp. (16%), Proteus group (including species of Proteus, Morganella and Providencia) (4.7%),
Enterococcus spp. (2.7%), Enterobacter spp. (2%), Pseudomonas spp. (1.1%) and others (2.9%).
There were significant differences in the percentage of uropathogens between males and
females for E. coli (61% vs. 73.6%, P = 0.0006) and Enterococcus spp. (5.2% vs. 1.9%,
P = 0.0143).
On comparing in-patients and out-patients, there were no significant differences in the
rates of positive, negative and contaminated samples. However, samples with the isolation of
two pathogens were more frequent among in-patients (8.6% vs. 4.1%, P = 0.0196). Regarding
the aetiology, microorganisms from the Proteus group and enterococci were more frequent
among in-patients (8% vs. 3.8%, P = 0.0261, and 5.2% vs. 2.1%, P = 0.0328, respectively)
whereas E. coli was more frequent among out-patients (62.6% vs. 72.5%, P = 0.0123). The rate
of reliable direct ID was 73% among in-patients vs. 82% among out-patients. Valid ID was
obtained in 84.3% of patients with positive urine culture and recorded a diagnosis of pyelone-
phritis (59 out of 70 with positive culture).
Table 2 shows the differences in cell count among positive, negative and contaminated
samples.
Valid ID by direct MALDI-ToF-MS was obtained in 72.8% of samples, in 80.3% of samples
positive by culture, 32.2% of contaminated samples, and 19.7% of negative samples. Among
positive samples with valid ID the concordance at the species level was 97.2% and 98.3% at the
genus level, and 12 samples (1.7%) showed a discordant result with the conventional ID
(Table 3).
Twelve samples (19.7%) with valid ID and negative by culture included: 4 E. coli, 1 Aerococ-
cus urinae, 1 Actinotignum schaalii, 1 Gardnerella vaginalis, 1 Streptococcus sp., 1 Lactobacillus
sp., 1 Alloscardovia omnicolens, 1 Corynebacterium riegelii and 1 Veillonella ratti.
Direct bacterial identification in urine
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Interestingly, on analysing a total of 1050 samples, we obtained a higher rate of valid direct
ID among samples without than with a preservative (76.4% vs. 70.4%, P = 0.0342).
Table 1. Characteristics of patients and samples included in the study.
Total Male Female P-value
Age
Mean (SD) 62.8 (21.7) 67.6 (17.2) 61.3 (22.7) <0.0001b
95% CI (61.5; 64.1) (65.4; 69.7) (59.8; 62.9)
In/out-patients
In-patients 192 (18.3%) 72 (29.5%) 120 (14.9%) <0.0001a
Out-patients 858 (81.7%) 172 (70.5%) 686 (85.1%)
Sample collection�
Midstream 980 (94.1%) 205 (85.8%) 775 (96.6%) <0.0001a
Indwelling catheter 35 (3.4%) 21 (8.8%) 14 (1.8%)
Catheterization 13 (1.2%) 6 (2.5%) 7 (0.9%)
Urostomy 13 (1.2%) 7 (2.9%) 6 (0.7%)
Urine collection system with a preservative
No 428 (40.8%) 112 (45.9%) 316 (39.2%) 0.0363a
Yes 622 (59.2%) 132 (54.1%) 490 (60.8%)
Urinary tract infection (UTI)��
Uncomplicated UTI 616 (79%) 111 (68.5%) 505 (81.7%) NA
Pyelonephritis 73 (9.4%) 27 (16.7%) 46 (7.4%)
Prostatitis 10 (1.3%) 10 (6.2%) -
No UTI 81 (10.4%) 14 (8.6%) 67 (10.8%)
Urine culture
Positive 902 (85.9%) 213 (87.3%) 689 (85.5%) 0.0462a
Contaminated 87 (8.3%) 24 (9.8%) 63 (7.8%)
Negative 61 (5.8%) 7 (2.9%) 54 (6.7%)
Mono/polymicrobial urine culture
Total of positive urine cultures 902 213 689
Monomicrobial 857 (95%) 197 (92.5%) 660 (95.8%) 0.0699a
Polymicrobial 45 (5%) 16 (7.5%) 29 (4.2%)
Cell count by flow cytometry
Epithelial cells
Median (Range) cells/μl 6.5 (0–495.6) 3.6 (0–447.1) 7.9 (0–495.6) <0.0001c
Red blood cells
Median (Range)
cells/μl
25.8 (0–4706) 39 (0–4706) 22.7 (0–2612) <0.0001c
White blood cells
Median (Range) cells/μl 194 (0–48,887) 552 (1–33,128) 146 (0–48,887) <0.0001c
Bacteria
Median (Range) bacteria/μl 20,206 (5002–454,734,000) 18,703 (5029/12,000,000) 20,518 (5002/454,734,000) 0.3513c
�Data available for 1041 samples: 239 from males and 802 from females
��Data available for 780 samples: 162 from males and 618 from females
a Fisher’s exact test
b Student’s t-test
c_Mann–Whitney U test.
SD: standard deviation; CI: confidence interval
https://doi.org/10.1371/journal.pone.0207822.t001
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Nevertheless, regarding only positive samples by culture, there was no significant difference
between the two groups (81.2% vs. 79.6%, P = 0.5562).
Table 4 shows the parameters associated with valid direct MALDI-ToF-MS ID on multivar-
iate analysis.
Additionally, we analysed the accuracy of bacterial morphology provided by flow cytometry
in 835 of 902 positive samples (92.6%), with 83 samples being reported as cocci/mixed and 752
as rods. In 67 positive samples no bacterial morphology was provided. The global concordance
was 92.1%. The sensitivity, specificity, positive predictive value and negative predictive value
was 92.8%, 73.3%, 98.9% and 27.5%, respectively for cultures positive for bacilli or mixed cul-
tures that included bacilli (Table 5).
Discussion
The usefulness of a combination of flow cytometry and MALDI-ToF-MS for direct identifica-
tion of pathogens in urine samples has been reported previously. The percentage of accuracy
Table 2. Cell count (median (range)) according to the positivity of the urine sample.
Median (Range) cells/μl Positive (902) Contaminated (87) Negative (67) P-value
EC 5.7 (0–447.1) 20.2 (0.2–495.6) 33.4 (0.5–167.7) <0.0001a
RBC 24.5 (0–4,706) 48.2 (2.1–1525.6) 27.9 (2.5–421.6) 0.0005a
WBC 194 (0–48,887) 253 (3–18,505) 168 (4–13,046) 0.4313a
Bacteria 21,752 (5,002–454,734,000) 12,401 (5,124/84,439) 8,016 (5,010/91,119) <0.0001a
a Kruskal-Wallis test
EC: epithelial cells; RBC: red blood cells; WBC: white blood cells
https://doi.org/10.1371/journal.pone.0207822.t002
Table 3. Results of routine identification and MALDI-ToF-MS direct ID in 902 culture positive samples.
Species Positive samples with valid
direct ID (n = 724)
Concordant samples between routine
and direct ID (n = 712)
Species level direct ID among
concordant samples (%)
Positive samples with no valid
direct ID (n = 178)
Escherichia coli 530 524a 524/524 (100) 107
Klebsiella spp. 117 114b 111/114 (97.4) 27
Proteus group 31 31 31/31 (100) 11
Enterobacter spp. 15 14c 12/14 (85.7) 3
Enterococcus spp. 10 8d 8/8 (100) 14
Citrobacter spp. 6 6 6/6 (100) 2
Pseudomonas spp. 6 6 5/6 (83.3) 4
Serratia marcescens 3 3 3/3 (100) 0
Streptococcus spp. 2 2 2/2 (100) 3
Aerococcus sp. 1 1 0/1 (0) 2
Staphylococcus sp. 1 1 1/1 (100) 4
Raoultella
ornithinolytica
1 1 1/1 (100) 0
Acinetobacter
baumannii
1 1 0/1 (0) 0
Oligella urethralis 0 - - 1
aDiscordant direct ID for 6 E. coli included 2 Lactobacillus spp., 1 Bifidobacterium breve, 1 Gardnerella vaginalis, 1 Aerococcus sp. and 1 Klebsiella pneumoniae
bDiscordant direct ID for 3 Klebsiella spp. included 1 Raoultella ornithinolytica, 1 Pseudomonas sp. and 1 Aerococcus sp.
cDiscordant direct ID for 1 Enterobacter aerogenes was Klebsiella pneumoniae
dDiscordant direct ID for 2 Enterococcus faecalis included 1 Raoultella ornithinolytica and 1 Lactobacillus sp.
https://doi.org/10.1371/journal.pone.0207822.t003
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in bacterial identification directly from the sample depends on several factors, with bacterial
count being the main factor. Samples with positive urine culture but with<105 CFU/ml show
a lower percentage of reliable direct identification compared to those with�105 CFU/ml [7,
15, 16]. Another variable that negatively influences direct identification is the presence of a sec-
ond pathogen. Wang et al. showed that the ratio of bacterial count between two pathogens
determines the possibility of a reliable identification of one of the pathogens [15]. This could
explain cases of valid identification obtained in contaminated samples due to the presence of a
dominant microorganism. From the multivariate analysis, we showed that the presence of a
high count of human cells such as WBC and EC associated negatively associated with a reliable
identification. Our data suggest that more sophisticated protocols of sample preparation
should be used if a high WBC count is detected by flow cytometry. Sanchez-Juanes et al. pro-
posed the treatment of urine samples with SDS solution to enhance direct identification [17].
Previous studies also demonstrated better results, if protein extraction was applied to the bac-
terial pellet [7, 18]. Veron et al. compared a filtration-based sample preparation protocol with
a differential centrifugation method and 5 hours of bacterial cultivation, obtaining better
results with the filtration protocol [19]. Recently, Kitagawa et al. implemented ultrasonic baths
to disperse bacterial aggregation prior to the centrifugation steps, improving the final identifi-
cation [20]. Another approach for the samples with a high bacterial as well as WBC count
could be a few hours of subculture on a solid medium prior to MALDI-ToF-MS ID [21]. The
presence of samples with a high EC count could indicate poor sample collection quality, and
these samples should not be processed for direct ID due to the increased probability of
contamination.
In the present study we used a lower score than recommended by the manufacturer to con-
sider a species ID as being reliable with MALDI-ToF-MS (1.7 vs 2.0). Although this could be
criticized, according to the experience of the authors, species ID with scores� 1.7 usually pro-
vide a reliable species level ID. Taking into account that we work with direct biological samples
with a complex composition, lower scores can be expected compared with colony-based ID. In
Table 4. Parameters associated with valid direct identification in positive urine samples.
OR CI 95% P-value
Centre <0.0001a
In-patients 0.516 0.314–0.848 0.0090
E. coli 2.073 1.386–3.099 0.0004
Bacterial morphology as Rods 2.292 1.299–4.045 0.0042
Log EC 0.849 0.737–0.977 0.0227
Log WBC 0.701 0.628–0.782 <0.0001
Log bacteria 2.206 1.662–2.928 <0.0001
athis variable was included in the analysis as the percentage of valid ID was different among centres
OR, Odds ratio; CI, Confidence Interval; EC: epithelial cells; WBC: white blood cells
https://doi.org/10.1371/journal.pone.0207822.t004
Table 5. Concordance between bacterial morphology provided by flow cytometry and culture results.
Number of samples according to
morphology
Rods by flow cytometry
(n = 752)
Cocci/mixed by flow cytometry
(n = 83)
Bacilli on culture (n = 786) 728 58
Bacilli and cocci mixed culture (n = 19) 16 3
Cocci on culture (n = 30) 8 22
https://doi.org/10.1371/journal.pone.0207822.t005
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the study published by March Rossello´ et al., the authors demonstrated that a lower score of
even less than 1.7 could be considered for direct ID from urine samples [18].
While samples from in-patients showed a lower probability of valid direct ID, the rate of
valid ID was sufficiently high to justify its application. Moreover, in this population, rapid ID
may have a greater impact on patient management, as the percentage of resistant microorgan-
isms, as well as species other than E. coli is higher [22].
We also analysed the presence of preservative substance in sample collection tubes. Preser-
vatives help to avoid cell destruction and bacterial proliferation [23, 24]. In the absence of pre-
servatives, contaminating flora may grow, while human cells are destroyed. This could explain
the higher percentage of valid ID in samples without a preservative, when we analysed a total
of samples, including contaminated ones. Among positive samples there were no significant
differences in the percentage of valid ID between these two groups. Therefore, the use of a pre-
servative could avoid valid direct ID of contaminated samples without affecting the rate of pos-
itive samples identified. Therefore, we recommend the use of preservatives for samples that
cannot be processed immediately (mainly samples from primary care), especially if an efficient
cold chain during transport is not assured.
Of 12 samples with discordant ID, in seven an identified microorganism usually grows with
difficulty in conventional media. These directly identified microorganisms were probably
present in the urine specimen in a higher concentration than the pathogen detected by the
conventional method. Five of the remaining discordant results were probably due to erroneous
ID by direct MALDI-ToF-MS or the routine method. Unfortunately, these discordant results
were not confirmed by 16S rRNA gene sequencing, as has been done in previous studies [15,
25]. Regarding negative samples with valid ID, four E. coli cases could be explained by the ther-
apy received (data not collected in this study). Other microorganisms showed fastidious
growth, and most seemed to be contaminant microorganisms.
Regarding the data on bacterial morphology, we obtained an acceptable positive predictive
value for bacilli. Nevertheless, we included only samples with a high bacterial count, and the
number of samples which were positive for cocci was low in this study. Previous data support
better results in predicting bacillary morphology with flow cytometry [26, 27].
Although the combination of flow cytometry and MALDI-ToF-MS could improve patient
management, especially in a hospital setting, direct identification includes many manual steps
that may impair implementation of this approach in routine laboratory work. Flow cytometry
analysis takes about one minute, but the median time required to prepare one sample for
MALDI-ToF-MS is about 20 min. Until a more automated process of sample preparation is
established, direct identification should only be used in some cases with great clinical impact,
such as those suspected of urinary sepsis and pyelonephritis.
Our study also suggests that different approaches should be studied and used for sample
processing depending on the presence of EC or WBC. Since a high EC count may indicate
probable sample contamination during sample collection, direct ID is not recommended due
to the risk of obtaining false positive results by contaminating flora. A high WBC count is a
good predictor of infection but may impair direct ID. We likely need to perform additional
studies to determine the WBC count cut-off in order to apply more rigorous sample prepara-
tion protocols including the use of agents such as SDS to enhance cell lysis or even opting for
short subcultures prior to MALDI-ToF-MS.
In summary, the results of this multicentre study confirm previously published data about
the usefulness and accuracy of direct MALDI-ToF-MS ID from urine samples. It was of note
that we observed an excellent concordance between direct and routine ID in all the participat-
ing centres without changing local urine processing protocols. Analysis of all the parameters
provided by flow cytometry is useful for evaluating the quality of sample collection, the
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feasibility of direct MALDI-ToF-MS ID and for deciding upon the most adequate sample
preparation protocol to be applied. Direct ID also allows the application of methods for anti-
microbial susceptibility testing or resistance detection from a direct clinical sample once a reli-
able ID is obtained [13, 14].
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